BriaCell Therapeutics Corp. Quarterly Common Stock, Value, Issued in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
BriaCell Therapeutics Corp. quarterly Common Stock, Value, Issued history and growth rate from Q2 2021 to Q1 2024.
  • BriaCell Therapeutics Corp. Common Stock, Value, Issued for the quarter ending April 30, 2024 was $69.6M, a 6.1% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $69.6M +$4M +6.1% Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $69.6M +$4M +6.1% Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $69.6M +$4M +6.1% Oct 31, 2023 10-Q 2023-12-14
Q2 2023 $69.6M +$4M +6.1% Jul 31, 2023 10-Q 2024-06-14
Q1 2023 $65.6M Apr 30, 2023 10-Q 2023-06-14
Q4 2022 $65.6M Jan 31, 2023 10-Q 2023-03-16
Q3 2022 $65.6M Oct 31, 2022 10-Q 2022-12-14
Q2 2022 $65.6M +$10.8M +19.7% Jul 31, 2022 10-K 2023-10-25
Q2 2021 $54.8M Jul 31, 2021 10-K 2022-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.